Capitainer
  • PRODUCT
    • CAPITAINER-B
      • HOW TO USE
      • INSTRUCTIONS FOR USE
      • INDICATION
      • SPECIFICATION
  • SCIENCE
    • TECH
    • PUBLICATIONS
  • NEWS
  • PRESS
  • ABOUT US
Välj en sida

Finger Prick Dried Blood Spots for HIV

Case Studies

”Finger Prick Dried Blood Spots for HIV Viral Load Measurement in Field Conditions in Zimbabwe”;

S. N. Mavedzenge, C. Davey, T. Chirenje, P. Mushati, S. Mtetwa, J. Dirawo, B. Mudenge, A. Phillips, F. M.Cowan. PLoS One. 2015 ; 10(5) : e0126878

https://www.ncbi.nlm.nih.gov/pubmed/26001044

Therapeutic Drug Monitoring by Dried Blood Spot Dried Blood Spot Analysis

News

  • Patent on the novel Capitainer B product approved in the US
  • Capitainer-B – “effectively assist in eliminating the hematocrit-based area bias”
  • Meet us at IATDMCT Congress in Brisbane 16-19/9
  • Meet us at AACC Annual Scientific Meeting
  • Capitainer B is CE-marked and is being made available for the European market!
  • Capitainer will attend Vårmöte i klinisk kemi 24-26 april 2018 in Uppsala
  • Meet us at Medtec Europe 17-19 april Messe, Stuttgart Germany

CAPITAINER AB
Norr Mälarstrand 54
112 20 Stockholm SWEDEN
Phone +46(0)70 897 75 77
info@capitainer.se

 

Our Partners

Vinnova
KTH Holding AB
EIT

About Us

Capitainer started in 2016.  Our technology is a volumetric blood collection device that enables patients to conveniently and safely collect blood samples in the comfort of their own home, our technology is more accurate than today’s solutions. Capitainer offers impressive cost and environmental savings for healthcare providers managing millions of  conventional blood samples annually.

CAPITAINER – A BLOOD SAMPLING REVOLUTION – COPYRIGHT 2019 –– DESIGN MADE BY FORMGARDA